<DOC>
	<DOCNO>NCT00230984</DOCNO>
	<brief_summary>Title : Effects home pulmonary rehabilitation patient chronic respiratory failure nutritional depletion . This randomize control , open clinical trial two group . - first group , 100 patient : control group , patient follow add-on intervention - Second group , 100 patient : rehabilitation group education , oral supplement , exercise androgenic steroid .</brief_summary>
	<brief_title>IRAD2 : Patients With Respiratory Failure Home</brief_title>
	<detailed_description>Title : Effects home pulmonary rehabilitation patient chronic respiratory failure nutritional depletion State art : The IRAD2 trial evaluate 3-month home intervention include education , oral supplement , exercise androgenic steroid undernourish patient chronic respiratory failure . The main objective increase six-minute walk distance 50 improvement health-related quality-of-life . Secondary end-points include reduction exacerbation rate 25 % , reduction health-related cost increase survival year follow intervention . Material method : This interventional , multi-centre , prospective , two-armed parallel , control trial conduct 200 patient . In group , `` Control '' `` Rehabilitation '' , 7 home visit schedule 3-month intervention education purpose . In `` Rehabilitation '' group , patient receive 160 mg/d oral testosterone undecanoate men , 80 mg/d woman , oral dietary supplement ( 563 kcal/d ) exercise ergometric bicycle 3 5 time week . Expected result : In event significant response intervention , trial would validate comprehensive global home-care undernourished patient chronic respiratory failure combine therapeutic education , oral supplement , androgenic substitution physical activity .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>well inform consent person woman old enough procreate Assisted respiratory treatment home 3 month : oxygenotherapy &gt; 8 hour per day and/or assist ventilation &gt; 6 hour per day . PaO2 without oxygenotherapy ≤ 8 kPa 60 mmHg ambient air begin assisted respiratory treatment . Affection : chronic obstructive bronchopneumopathy , diffuse bronchial dilatation , non neuromuscular restrictive syndrome ( pulmonary diffuse infiltration , parietal lesion ) obstructive restrictive syndrome . malnourish person , one follow criterion : Body Mass Index ≤ 21kg/m2 weight loss ( 10 % previous weight ) nonfatty mass measure 50 Hz impedancemetry ≤25th percentile ≤ 63 % ideal weight woman , ≤ 67 % ideal weight men . Sleep apnea daytime drowsiness ( drowsiness scale Epworth &gt; 9/24 ) Known pathology reduce vital prognosis 6 month ( AIDS , cancer ... ) . History hormone dependent cancer ( breast cancer , prostate cancer ) , pathologic Prostate Specific Antigen . Inability follow rehabilitation program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Chronic Respiratory Failure</keyword>
	<keyword>Pulmonary Rehabilitation</keyword>
	<keyword>Nutritional Depletion</keyword>
	<keyword>Home</keyword>
	<keyword>COPD</keyword>
	<keyword>Oral Dietary Supplements</keyword>
	<keyword>Therapeutic Education</keyword>
	<keyword>Androgens</keyword>
	<keyword>Exacerbation</keyword>
	<keyword>Survival</keyword>
</DOC>